The flow cytometry-based assay measures the expression of the protein FcyR11a as a biomarker for cardiovascular risk.

Chancellor tells the City she is “clear that the financial services sector must play a central part in our economic vision ...

The FDA has granted a de novo clearance to a wearable device—with a form factor you’re familiar with—that can check patients ...

Doubleview will issue a total of 8,389,583 flow-through shares (the "FT Shares") at a price of $0.48 per FT Share for gross proceeds of $4,026,999.84.

The Surgical Equipment Market, valued at USD 35.41 billion in 2023, is expected to grow at a compound annual growth rate (CAGR) of 9.74 ...

Primary care clinicians and practices are uniquely positioned to help people achieve optimal cardiovascular health through screening, diagnosing and treating the health behaviors and factors outlined ...